Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). ClearPoint Neuro's share price for the quarter that ended in Dec. 2023 was $6.79. ClearPoint Neuro's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 24.65 Mil. Therefore, ClearPoint Neuro's market cap for the quarter that ended in Dec. 2023 was $167.39 Mil.
ClearPoint Neuro's quarterly market cap
declined
from Jun. 2023 ($178.30 Mil) to Sep. 2023 ($123.37 Mil) but then
increased
from Sep. 2023 ($123.37 Mil) to Dec. 2023 ($167.39 Mil).
ClearPoint Neuro's annual market cap
declined
from Dec. 2021 ($265.53 Mil) to Dec. 2022 ($208.18 Mil) and
declined
from Dec. 2022 ($208.18 Mil) to Dec. 2023 ($167.39 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. ClearPoint Neuro's Enterprise Value for Today is $135.08 Mil.
ClearPoint Neuro Market Cap Historical Data
The historical data trend for ClearPoint Neuro's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ClearPoint Neuro's Market Cap
For the Medical Devices subindustry, ClearPoint Neuro's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ClearPoint Neuro's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ClearPoint Neuro's Market Cap distribution charts can be found below:
* The bar in red indicates where ClearPoint Neuro's Market Cap falls into.
ClearPoint Neuro Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
ClearPoint Neuro's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ClearPoint Neuro (NAS:CLPT) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
ClearPoint Neuro Market Cap Related Terms
Thank you for viewing the detailed overview of ClearPoint Neuro's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
ClearPoint Neuro (ClearPoint Neuro) Business Description
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use in the United States, is used to perform minimally invasive surgical procedures in the brain and ClearTrace is used to perform minimally invasive surgical procedures in the heart. The company's products and product candidates include ClearPoint neuro system, MRI-guided drug delivery, and Thermal therapy system.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CLPT has been successfully added to your 